LEADER 04429oam 2201057zu 450 001 9910830458703321 005 20230422043308.0 010 $a1-280-55486-X 010 $a9786610554867 010 $a0-470-85202-X 010 $a0-470-84633-X 035 $a(CKB)1000000000019180 035 $a(SSID)ssj0000294353 035 $a(PQKBManifestationID)11244142 035 $a(PQKBTitleCode)TC0000294353 035 $a(PQKBWorkID)10311742 035 $a(PQKB)10835378 035 $a(MiAaPQ)EBC4956270 035 $a(Au-PeEL)EBL4956270 035 $a(CaONFJC)MIL55486 035 $a(OCoLC)55689482 035 $a(EXLCZ)991000000000019180 100 $a20160829d1999 uy 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDrug regimen compliance : issues in clinical trials and patient management 210 31$a[Place of publication not identified]$cWiley$d1999 215 $a1 online resource (203 pages) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-471-97122-7 330 $aDrug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Metry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to: Address key topics, such as regulatory issues and the role of compliance in clinical care Provide pointers for trials Provide guidelines for the management of patients Explore means by which compliance can be monitored Suggest the best ways to monitor patient management Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens. 606 $aPatient compliance$xDosage 606 $aDrugs 606 $aClinical trials 606 $aClinical Trials as Topic 606 $aPatient Compliance 606 $aPharmaceutical Preparations 606 $aPatient Acceptance of Health Care 606 $aEvaluation Studies as Topic 606 $aHealth Behavior 606 $aEpidemiologic Methods 606 $aBehavior 606 $aInvestigative Techniques 606 $aHealth Care Evaluation Mechanisms 606 $aAttitude to Health 606 $aBehavior and Behavior Mechanisms 606 $aPublic Health 606 $aQuality of Health Care 606 $aDelivery of Health Care 606 $aHealth Care Quality, Access, and Evaluation 606 $aEnvironment and Public Health 606 $aHealth Care 606 $aMedical Professional Practice$2HILCC 606 $aMedicine$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 0$aPatient compliance$xDosage 615 0$aDrugs 615 0$aClinical trials 615 2$aClinical Trials as Topic 615 2$aPatient Compliance 615 2$aPharmaceutical Preparations 615 2$aPatient Acceptance of Health Care 615 2$aEvaluation Studies as Topic 615 2$aHealth Behavior 615 2$aEpidemiologic Methods 615 2$aBehavior 615 2$aInvestigative Techniques 615 2$aHealth Care Evaluation Mechanisms 615 2$aAttitude to Health 615 2$aBehavior and Behavior Mechanisms 615 2$aPublic Health 615 2$aQuality of Health Care 615 2$aDelivery of Health Care 615 2$aHealth Care Quality, Access, and Evaluation 615 2$aEnvironment and Public Health 615 2$aHealth Care 615 7$aMedical Professional Practice 615 7$aMedicine 615 7$aHealth & Biological Sciences 676 $a615/.1 702 $aMâetry$b Jean-Michel 702 $aMeyer$b Urs A 702 $aMétry$b Jean-Michel 801 0$bPQKB 906 $aBOOK 912 $a9910830458703321 996 $aDrug regimen compliance : issues in clinical trials and patient management$94020845 997 $aUNINA